Overview / Abstract: |
Target Audience Program Overview Learning Objectives Review immunotherapies and therapy combinations for the management of both malignant RCC and adjuvant treatment |
Expiration |
Mar 16, 2024 |
Discipline(s) |
Physician CME |
Format |
Online |
Credits / Hours |
1.0 |
Accreditation |
ACCME, ACPE, ANCC |
Presenters / Authors / Faculty |
Pedro Barata, MD, MSc |
Sponsors / Supporters / Grant Providers |
Merck |
Keywords / Search Terms |
Relias LLC Relias, Free CME, renal cell carcinoma (RCC) Free CE CME |